Status:
COMPLETED
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
Lead Sponsor:
Takeshi Morimoto
Collaborating Sponsors:
University of the Ryukyus
Conditions:
Type 2 Diabetes
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether intensive blood pressure and low density lipoprotein (LDL) cholesterol lowering could improve survival and cardiovascular outcome in Japanese diabetic...
Detailed Description
Prevalence of type 2 diabetes in Asia seems to be almost epidemic and establishment of preventive strategy against macrovascular as well as microvascular diseases are warranted because of higher cardi...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients with coronary artery disease and history of acute coronary syndrome
- Patients whose blood pressure and LDL cholesterol levels are above values recommended by the current guideline
Exclusion
- Patients who have active malignant tumor
- Patients who are on hemodialysis due to end stage kidney disease
- Patients whom statins are contraindicated
- Patients who had acute coronary syndrome or stroke within 3 months
- Patients who are pregnant or on breast feeding
- Patients whose physicians deem that attending this trial is contraindicated or inappropriate
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
798 Patients enrolled
Trial Details
Trial ID
NCT01422421
Start Date
August 1 2011
End Date
December 31 2023
Last Update
June 14 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, University of the Ryukyus
Nishihara, Okinawa, Japan, 903-0215
2
Saga University Hospital
Saga, Japan, 849-8501